Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > What has happened with this PILL ?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by JRSDIRECTon Jun 08, 2018 3:11pm
64 Views
Post# 28147479

RE:RE:RE:RE:RE:RE:RE:What has happened with this PILL ?

RE:RE:RE:RE:RE:RE:RE:What has happened with this PILL ?Re Tonyde; I didn't take any disrespect in your question or rebuttal. I saw the error in my post that I was referring to the Canadian market. I've never been one to turn away constructive conversation or to be malice when directed to an error in my postings. The tablet is currently deemed to be an 'edible' as it is not consumed in a leaf (smoking) or oil. It's ingested orally. The PR back in May stated to market in 2019. And all other form of edibles will not become legal for 1 year post legalization as the government needs to understand the mandates of these products and how they are sold and controlled. I have to find the source but I remember reading about Cannatab that they were not happy with the 'edible' classification because their product (their intention) is to serve the medicinal market and most edibles (brownie, lollipops etc) that are coming to market infused with MJ are for the recreational market but they are still all falling under the same classification Hence I default back to the current 1 year gap to allow the Canadian market to start to work on and manage this sector of the market.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities